doi: 10.1136/jcp.2004.022681 89 LandeAFlugeStrandEBFlmSTSosaDDMellaOet al
Common Peptide/GLP-1 Complications and Side Effects Even though many patients tolerate these therapies well, complications are not uncommon
In this study, patients were stabilized on optimum dosages of their concomitant AEDs during an 8-week baseline phase
Why the Separate Combination Is Used Instead of Qsymia Although Qsymia provides a convenient once daily extended release formulation, it can be expensive and is not always covered by insurance
However, currently the use of GLP-1 RAs is not recommended as treatment of MASLD.(3) The American Diabetes Association 2025 guidelines similarly state GLP-1 RAs are recommended in adults with diabetes, obesity, and MASLD in combination with diet and exercise for weight loss
In response, congress passed the Food, Drug, and Cosmetic Act in 1938